会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明授权
    • Mixture of catenate and cyclic siloxane oligomers, its preparation and use
    • 联苯胺和环状硅氧烷低聚物的混合物,其制备和用途
    • US06780955B2
    • 2004-08-24
    • US10348959
    • 2003-01-23
    • Dieter BarfurthHelmut Mack
    • Dieter BarfurthHelmut Mack
    • C08G7708
    • C08G77/20C08G77/045C08G77/06C09D183/04
    • The present invention provides a process for preparing a mixture, which mixture includes catenate and cyclic siloxanes of formula I R3Si—O—(SiR2—O—)mSiR3   (I) and cyclic siloxanes of formula II wherein m is an integer from 0 to 40 and n is an integer from 2 to 40, wherein R2 and R3 are each independently an organic functional group selected from the group including alkyl, aryl, vinyl, and alkoxy groups, and wherein there is not more than one vinyl group or aryl group per silicon atom, said process including a controlled hydrolysis, condensation or cocondensation reaction of at least one monomeric silane in alcoholic solution in the presence of an acidic catalyst, which reaction includes contacting alcohol, water, and at least one chlorosilane component selected from the group including (i), (ii), (iii): (i) at least one arylchlorosilane; (ii) at least one admixture selected from the group including alkylchlorosilane and arylchlorosilane, arylchlorosilane and vinylchlorosilane, alkylchlorosilane and vinylchlorosilane, and arylchlorosilane and vinylchlorosilane and alkylchlorosilane; (iii) at least one selected from the group including chlorosilane, alkylchlorosilane, arylchlorosilane, and vinylchlorosilane in two or more separate batches to obtain two or more separate mixtures and thereafter combining the mixtures; to form the mixture of the catenate and cyclic siloxanes. The present invention also provides the mixtures and the use of such mixtures.
    • 本发明提供一种制备混合物的方法,该混合物包括式I的链环和环状硅氧烷和式II的环状硅氧烷,其中m为0至40的整数,n为2至40的整数,其中R 2和R 3各自为 独立地是选自包括烷基,芳基,乙烯基和烷氧基的有机官能团,并且其中每个硅原子不超过一个乙烯基或芳基,所述方法包括受控的水解,缩合或共缩聚反应 在酸性催化剂存在下,醇溶液中的至少一种单体硅烷,该反应包括使醇,水和至少一种选自(i),(ii),(iii):(i)中的氯硅烷组分与 至少一种芳基氯硅烷;(ii)至少一种选自烷基氯硅烷和芳基氯硅烷,芳基氯硅烷和乙烯基氯硅烷,烷基氯硅烷和乙烯基氯硅烷的混合物, nd芳基氯硅烷和乙烯基氯硅烷和烷基氯硅烷;(iii)选自包括氯硅烷,烷基氯硅烷,芳基氯硅烷和乙烯基氯硅烷的组中的至少一种,分两批以上分批,以获得两种或更多种分离的混合物,然后混合该混合物; 链状和环状硅氧烷。 本发明还提供了这些混合物的混合物和用途。
    • 39. 发明授权
    • Carboxamide compounds and their use as calpain inhibitors V
    • 羧酰胺化合物及其作为钙蛋白酶抑制剂的用途
    • US09062027B2
    • 2015-06-23
    • US13992582
    • 2011-12-08
    • Andreas KlingKatja JantosHelmut MackAchim MollerWilfried HornbergerYanbin LaoGisela BackfischMarjoleen Nijsen
    • Andreas KlingKatja JantosHelmut MackAchim MollerWilfried HornbergerYanbin LaoGisela BackfischMarjoleen Nijsen
    • C07D401/14C07D401/04A61K31/4439A61P25/28
    • C07D401/04A61K31/4439C07D401/14Y02A50/411
    • The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3, R4, X, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted benzyl or hetaryl-methyl, X is a single bond or an oxygen atom, R2 is C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, C3-C6-heterocycloalkyl-C1-C2-alkyl, phenyl, phenyl-C1-C3-alkyl, pyridin-2-yl-C1-C3-alkyl or CH2—C(O)OCH3, R3 and R4 independently of one another are halogen, CN, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.
    • 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式(I)的化合物,其中R 1,R 2,R 3,R 4,X,m和n具有权利要求书和描述中所述的含义,其互变异构体,其水合物和药学上合适的盐 其中。 在这些化合物中,优选其中R 1为任选取代的苄基或杂芳基 - 甲基,X为单键或氧原子,R 2为C 1 -C 4烷基,C 1 -C 4卤代烷基,C 2 -C 4 - 烯基,C 3 -C 6 环烷基,C 3 -C 6环烷基-C 1 -C 2烷基,C 3 -C 6杂环烷基-C 1 -C 2烷基,苯基,苯基-C 1 -C 3 - 烷基,吡啶-2-基-C 1 -C 3 - 烷基或CH 2 -C(O)OCH 3,R 3和R 4彼此独立地是卤素,CN,CF 3,CHF 2,CH 2 F,C 1 -C 2 - 烷基或C 1 -C 2 - 烷氧基,m和n彼此独立地为0或1。
    • 40. 发明授权
    • Carboxamide compounds and their use as calpain inhibitors V
    • 羧酰胺化合物及其作为钙蛋白酶抑制剂的用途
    • US09051304B2
    • 2015-06-09
    • US12972663
    • 2010-12-20
    • Andreas KlingKatja JantosHelmut MackAchim MöllerWilfried HornbergerGisela BackfischYanbin LaoMarjoleen Nijsen
    • Andreas KlingKatja JantosHelmut MackAchim MöllerWilfried HornbergerGisela BackfischYanbin LaoMarjoleen Nijsen
    • C07D401/04C07D401/14C07D207/28C07D409/14C07D417/14
    • C07D401/04C07D207/28C07D401/14C07D409/14C07D417/14
    • The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3 R4, R5, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted phenyl-C1-C2-alkyl or hetaryl-C1-C2-alkyl, R2 is optionally substituted aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl or hetaryl-C1-C4-alkyl, R3 is C1-C3-alkyl, C1-C3-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, or phenyl-C1-C3-alkyl, R4 and R5 independently of one another are halogen, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.
    • 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式I的化合物,其中R 1,R 2,R 3,R 4,R 5,m和n具有权利要求书和描述中所述的含义,其互变异构体,其水合物及其药学上合适的盐。 在这些化合物中,优选其中R 1为任选取代的苯基-C 1 -C 2烷基或杂芳基-C 1 -C 2烷基,R 2为任选取代的芳基,杂芳基,芳基-C 1 -C 6 - 烷基,芳基-C 2 -C 6 - 烯基 或杂芳基-C 1 -C 4 - 烷基,R 3是C 1 -C 3 - 烷基,C 1 -C 3 - 卤代烷基,C 2 -C 4 - 烯基,C 3 -C 6 - 环烷基,C 3 -C 6 - 环烷基-C 1 -C 2烷基或苯基 - C 1 -C 3 - 烷基,R 4和R 5彼此独立地是卤素,CF 3,CHF 2,CH 2 F,C 1 -C 2 - 烷基或C 1 -C 2 - 烷氧基,m和n彼此独立地为0或1。